Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-09-020820
Filing Date
2009-04-15
Accepted
2009-04-15 17:20:15
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 v146263_10k.htm 10-K 2142707
2 GRAPHIC graphic1.jpg GRAPHIC 17087
3 GRAPHIC graphic2.jpg GRAPHIC 12706
4 v146263_ex31-1.htm EX-31.1 15869
5 v146263_ex31-2.htm EX-31.2 15363
6 v146263_ex32-1.htm EX-32.1 9727
7 v146263_ex32-2.htm EX-32.2 9427
  Complete submission text file 0001144204-09-020820.txt   2235984
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

EIN.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32581 | Film No.: 09751974
SIC: 2834 Pharmaceutical Preparations